1. Home
  2. RZLT vs FLYX Comparison

RZLT vs FLYX Comparison

Compare RZLT & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$1.84

Market Cap

187.3M

Sector

Health Care

ML Signal

HOLD

Logo flyExclusive Inc.

FLYX

flyExclusive Inc.

HOLD

Current Price

$3.20

Market Cap

79.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RZLT
FLYX
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
187.3M
79.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RZLT
FLYX
Price
$1.84
$3.20
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.33
N/A
AVG Volume (30 Days)
12.5M
15.0K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$362,955,000.00
Revenue This Year
N/A
$28.47
Revenue Next Year
N/A
$22.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.38
52 Week Low
$1.07
$1.90
52 Week High
$11.46
$6.90

Technical Indicators

Market Signals
Indicator
RZLT
FLYX
Relative Strength Index (RSI) 24.57 49.17
Support Level $1.07 $3.08
Resistance Level $2.25 $4.22
Average True Range (ATR) 0.60 0.38
MACD -0.77 -0.02
Stochastic Oscillator 7.13 35.95

Price Performance

Historical Comparison
RZLT
FLYX

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: